Is a carbon dioxide (CO2) level increase from 33 to 39 millimeters of mercury (mmHg) significant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is a CO2 Increase from 33 to 39 mmHg Clinically Significant?

Yes, a rise in CO2 from 33 to 39 mmHg is clinically significant and requires immediate assessment of the clinical context, respiratory status, and underlying conditions to determine if this represents acute respiratory compromise, chronic compensation, or a concerning trend toward respiratory failure. 1, 2

Understanding the Change

The magnitude and direction of this change matter more than the absolute values:

  • Normal arterial PCO2 ranges from 35-45 mmHg, with 40 mmHg being the typical reference point 3, 2
  • The initial value of 33 mmHg represents mild hypocapnia (low CO2), which can cause cerebral vasoconstriction and reduce cerebral blood flow to 79% of baseline 1
  • The rise to 39 mmHg brings the patient into the normal range, but the 6 mmHg increase itself is the critical finding 1

Clinical Significance Depends on Context

In Brain-Injured or Critically Ill Patients

This change is highly significant and potentially dangerous:

  • The American College of Critical Care Medicine recommends avoiding rapid changes in CO2, specifically defining ΔPaCO2 >20 mmHg within 24 hours as dangerous 1
  • While this 6 mmHg change is below that threshold, any rapid CO2 shift in brain-injured patients requires close monitoring 1
  • A PaCO2 of 30 mmHg reduces cerebral blood flow to 79% of baseline, while 40 mmHg maintains normal baseline flow (98-100%) 1
  • The transition from 33 to 39 mmHg represents improved cerebral perfusion, but the rate of change must be controlled 1

In Patients with Chronic Respiratory Disease

This may represent early decompensation:

  • In COPD patients, a baseline PaCO2 of 33 mmHg would be unusually low, suggesting either acute hyperventilation or measurement error 2
  • A rise to 39 mmHg could indicate worsening respiratory mechanics, increased work of breathing, or respiratory muscle fatigue 2
  • Patients with chronic lung disease often have compensated hypercapnia at baseline, but acute rises signal deterioration 2

In Post-Cardiac Arrest or ECPR Patients

This change requires immediate intervention:

  • The American Heart Association recommends targeting PaCO2 35-45 mmHg and strictly avoiding rapid changes 1
  • Rapid CO2 fluctuations are associated with intracranial hemorrhage and increased mortality 1
  • Temperature correction must be applied if the patient is hypothermic, as laboratory-reported values may be falsely elevated 1

Assessment Algorithm

Follow this structured approach to determine significance:

  1. Identify the measurement source:

    • If arterial blood gas: represents true respiratory status 2
    • If venous blood gas: less reliable for respiratory assessment 2
    • If basic metabolic panel "CO2": reflects bicarbonate, not PCO2 4
  2. Assess the timeframe:

    • Change over minutes to hours: suggests acute respiratory compromise 1, 2
    • Change over days: may represent metabolic compensation or chronic process 2
    • Any change >20 mmHg in 24 hours: dangerous in brain-injured patients 1
  3. Evaluate clinical context:

    • Respiratory distress signs: accessory muscle use, paradoxical breathing, inability to speak in full sentences 2
    • Mental status: declining consciousness with rising CO2 requires ICU escalation 2
    • Underlying conditions: COPD, neuromuscular disease, brain injury, heart failure 1, 2
  4. Check arterial blood gas with pH:

    • pH <7.35 with rising CO2: acute respiratory acidosis 2, 4
    • pH normal with rising CO2: chronic compensated state 4
    • pH >7.45 with rising CO2: metabolic alkalosis (if from BMP) 4

Management Approach

Immediate Actions

If acute respiratory compromise is suspected:

  • Ensure adequate oxygenation while monitoring for CO2 retention 2
  • In COPD patients, target oxygen saturations of 88-92% to avoid worsening hypercapnia 2
  • Consider non-invasive ventilation if pH <7.35 with rising CO2 2
  • Obtain arterial blood gas to confirm respiratory status and assess pH 2

Monitoring Requirements

The American Association for Respiratory Care recommends:

  • Continuous end-tidal CO2 monitoring with regular arterial blood gas confirmation 1
  • Serial measurements every 2-4 hours if CO2 is rising 2
  • Assess for signs of respiratory muscle fatigue or increased work of breathing 2

Critical Thresholds for Escalation

Transfer to ICU immediately if:

  • Declining mental status with rising CO2 2
  • pH <7.25 on arterial blood gas 2
  • Respiratory rate >30 or <8 breaths per minute 2
  • Inability to protect airway 2

Common Pitfalls to Avoid

Do not dismiss this change as "still within normal range":

  • The trend is more important than the absolute value 1, 2
  • A patient moving from hypocapnia to normocapnia may be improving, but one moving from normocapnia toward hypercapnia is deteriorating 1, 2

Do not rapidly correct CO2 in chronic hypercapnia:

  • The American College of Critical Care Medicine recommends never rapidly decreasing PaCO2 in patients with chronic or acute hypercarbia 1
  • Rapid changes can cause intracranial hemorrhage and increased mortality 1

Do not confuse BMP "CO2" with arterial PCO2:

  • BMP measures bicarbonate (metabolic), not respiratory CO2 4
  • Arterial blood gas is required to assess respiratory status 2, 4

In brain-injured patients, do not allow hypocapnia:

  • Hypocapnia (PaCO2 <35 mmHg) independently predicts unfavorable neurological outcomes 1
  • The initial value of 33 mmHg was already concerning; the rise to 39 mmHg may represent appropriate correction 1

References

Guideline

Management of Hypercarbia and Brain Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hypercapnia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acid-Base Disorders and Bicarbonate Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.